AbCellera Biologics Inc.
ABCL
Kedudukan dalam Saham
#4083
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Harga Saham
$12.29
Modal Pasaran
$3.98B
Perubahan (1 hari)
4.95%
Perubahan (1 tahun)
120.25%
Negara
CA
Perdagangan AbCellera Biologics Inc. (ABCL)
Kategori
Healthcare
Sejarah harga saham bagi AbCellera Biologics Inc. (ABCL)
Harga penutupan tertinggi: $12.67 pada 2026-10-01
Harga penutupan terendah: $45.73 pada 2020-12-01
Harga penutupan terendah: $45.73 pada 2020-12-01
Sejarah harga saham AbCellera Biologics Inc. dari 2020 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | 69.39% |
| 2025 | 23.13% |
| 2024 | -44.83% |
| 2023 | -50.84% |
| 2022 | -25.40% |
| 2021 | -68.67% |
| 2020 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
